Lack of Diversity in Clinical Trials is a Danger to Multiple Sclerosis Patients
According to an article at Multiple Sclerosis News Today, at least one doctor at U.K. Healthcare's Kentucky Neuroscience Institute wants more diversity in clinical trials. It's not just about social…